Literature DB >> 24166144

Dialysis: Systemic IL-6 levels predict survival after peritoneal dialysis.

Roberto Pecoits-Filho1, Thyago P de Moraes.   

Abstract

In a recent study, Lambie and colleagues suggest that systemic and local intraperitoneal inflammation, evidenced by elevated levels of interleukin-6, are independent processes and have different consequences for patients undergoing peritoneal dialysis. Prevention of inflammation in these patients will, therefore, require different therapeutic approaches.

Entities:  

Mesh：

Year:  2013        PMID： 24166144     DOI： 10.1038/nrneph.2013.231

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

Review 1.  Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions.

Authors:  John D Williams; Kathrine J Craig; Nicholas Topley; Geraint T Williams
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

2.  Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?

Authors:  Deirisa Lopes Barreto; Annemieke M Coester; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2013-09-01       Impact factor: 1.756

3.  Applying translational research in understanding complications and defining targets for intervention: inflammation in PD as a model.

Authors:  Roberto Pecoits-Filho
Journal:  Perit Dial Int       Date:  2009 Mar-Apr       Impact factor: 1.756

4.  Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival.

Authors:  Mark Lambie; James Chess; Kieron L Donovan; Yong Lim Kim; Jun Young Do; Hi Bahl Lee; Hyunjin Noh; Paul F Williams; Andrew J Williams; Sara Davison; Marc Dorval; Angela Summers; John D Williams; John Bankart; Simon J Davies; Nicholas Topley
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

5.  Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.

Authors:  Roberto Pecoits-Filho; Maria João Carvalho; Peter Stenvinkel; Bengt Lindholm; Olof Heimbürger
Journal:  Perit Dial Int       Date:  2006 Jan-Feb       Impact factor: 1.756

6.  Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate.

Authors:  Roberto Pecoits-Filho; Maria Regina T Araújo; Bengt Lindholm; Peter Stenvinkel; Hugo Abensur; João Egídio Romão; Marcelo Marcondes; André H Freiria De Oliveira; Irene L Noronha
Journal:  Nephrol Dial Transplant       Date:  2002-08       Impact factor: 5.992

7.  Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.

Authors:  Anabela S Rodrigues; Margarida Martins; Johanna C Korevaar; Sandra Silva; José C Oliveira; Antonio Cabrita; João Castro e Melo; Raymond T Krediet
Journal:  Am J Nephrol       Date:  2007-02-06       Impact factor: 3.754

8.  Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.

Authors:  Kook-Hwan Oh; Ji Yong Jung; Myeong Ok Yoon; Aeran Song; Hajeong Lee; Han Ro; Young-Hwan Hwang; Dong Ki Kim; Peter Margetts; Curie Ahn
Journal:  Nephrol Dial Transplant       Date:  2010-01-08       Impact factor: 5.992

9.  Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients.

Authors:  Jeffrey Perl; Kit Huckvale; Michelle Chellar; Biju John; Simon J Davies
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-28       Impact factor: 8.237

10.  Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment.

Authors:  Roberto Pecoits-Filho; Peter Bárány; Bengt Lindholm; Olof Heimbürger; Peter Stenvinkel
Journal:  Nephrol Dial Transplant       Date:  2002-09       Impact factor: 5.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.